| Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
| Q57997898 | 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary |
| Q37783500 | A review of the use of common antiplatelet agents in orthopaedic practice |
| Q35790295 | Advances in nuclear cardiology: preoperative risk stratification |
| Q36046070 | Advances in nuclear imaging for preoperative risk assessment |
| Q53105209 | Antiplatelet and anticoagulation therapy in microlaryngeal surgery. |
| Q37969848 | Antiplatelet therapy in ENT surgery: a review |
| Q36941850 | Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives |
| Q46738760 | Aspirin and clopidogrel use in the perioperative period for non-cardiac surgery |
| Q38178106 | Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review |
| Q38165873 | Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside |
| Q37997017 | Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents |
| Q37551923 | Cangrelor: a novel P2Y12 receptor antagonist |
| Q30371026 | Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention |
| Q37980467 | Clopidogrel dilemma for orthopaedic surgeons |
| Q36095492 | Complete myocardial revascularization: between myth and reality |
| Q35975712 | Complications of major aortic and lower extremity vascular surgery |
| Q40148075 | Coronary Angiography and Revascularization Prior to Noncardiac Surgery. |
| Q36645771 | Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions |
| Q28221838 | Coronary stents, dual antiplatelet therapy and peri-operative problems |
| Q42933146 | Current aspects of anesthetic management in urological patients |
| Q44510213 | Drug-eluting stents versus bare metal stents prior to noncardiac surgery |
| Q41862704 | Early surgery after coronary revascularization: a fine line between bleeding and thrombosis |
| Q85275096 | Effect of antiplatelet therapy on patients undergoing gastroenterological surgery: thromboembolic risks versus bleeding risks during its perioperative withdrawal |
| Q36836440 | Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery |
| Q36834437 | Evidence-based guide to perioperative medicine |
| Q33159170 | Frequency and risk of noncardiac surgery after drug-eluting stent implantation. |
| Q37293250 | How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery. |
| Q48893357 | Ideal peri-operative management of patients with cardiovascular disease: the quest continues |
| Q59695719 | Impact of bivaluridin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndrome |
| Q39651758 | Intractable intraoperative bleeding requiring platelet transfusion during emergent cholecystectomy in a patient with dual antiplatelet therapy after drug-eluting coronary stent implantation (with video). |
| Q45121029 | Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. |
| Q44952705 | Management of patients with coronary stents in elective thoracic surgery |
| Q37782234 | Management of patients with coronary stents in the ICU |
| Q37912273 | Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. |
| Q42969651 | Management of perioperative stent thrombosis in patients undergoing surgery |
| Q37638183 | Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures |
| Q40356537 | Mortality Risk Assessment of Total Knee Arthroplasty and Related Surgery After Percutaneous Coronary Intervention |
| Q98222208 | Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management |
| Q38271548 | Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management |
| Q42156728 | Patient with recent coronary artery stent requiring major non cardiac surgery |
| Q38107887 | Patients who require non-cardiac surgery in acute coronary syndrome |
| Q42167155 | Patients with coronary artery stents: when and how should operations be carried out? |
| Q36708925 | Perioperative Management to Reduce Cardiovascular Events |
| Q38012080 | Perioperative antiplatelet management in patients with coronary artery stenting |
| Q83470362 | Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery |
| Q46244379 | Perioperative discontinuation of antiplatelet therapy of patients with coronary stents. Reevaluating the risks |
| Q45966223 | Perioperative handling of patients on antiplatelet therapy with need for surgery. |
| Q36111081 | Perioperative management of a patient with recently placed drug-eluting stents requiring urgent spinal surgery. |
| Q47659030 | Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review. |
| Q38084549 | Perioperative management of antiplatelet therapy in patients with drug-eluting stents. |
| Q41892630 | Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection |
| Q36552085 | Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients? |
| Q37992531 | Preoperative cardiac evaluation of the vascular surgery patient--an anesthesia perspective |
| Q94467409 | Preoperative evaluation and treatment of stable CAD in patients scheduled for major elective vascular surgery |
| Q30409694 | Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting |
| Q92929839 | Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence |
| Q51778480 | Report of simultaneous off-pump CABG and modified mastectomy. |
| Q35758378 | Risk is not our business: safety of thoracic surgery in patients using antiplatelet therapy. |
| Q37822725 | Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery |
| Q92925909 | Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery |
| Q35106803 | Role of cardiac evaluation before thoracic endovascular aortic repair |
| Q37139276 | Safety of drug-eluting stents |
| Q46138029 | Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding? |
| Q36360162 | Stents or surgery: the case for stents |
| Q42266052 | Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent |
| Q38043568 | Surgical management of coronary artery disease associated with malignancy |
| Q36269072 | Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review |
| Q42001327 | The avantgarde carbostent in patients scheduled for undelayable noncardiac surgery |
| Q37808050 | The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery |
| Q37194881 | The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors |
| Q36945252 | The risk of drug-eluting stent thrombosis with noncardiac surgery |
| Q43246022 | The risk of stent thrombosis in the perioperative setting |
| Q37231434 | The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection |
| Q79359221 | Update in perioperative medicine |
| Q38624959 | What is the optimal perioperative management of antiplatelet therapy? |
| Q84229903 | [Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty] |
| Q79968288 | [Antithrombotic drugs in urological surgery. Treatment interfering with haemostasis in urology?] |
| Q80542358 | [Diagnostic flexible bronchoscopy. Recommendations of the Endoscopy Working Group of the French Society of Pulmonary Medicine] |
| Q79702252 | [Fibreoptic bronchoscopy and anti-platelet agents: a risk-benefit analysis] |
| Q79553844 | [Hip surgery immediately following stent revascularization of an acute myocardial infarction] |
| Q79331079 | [Interactions between cardiovascular drugs and anesthesia and surgery] |
| Q84707921 | [Perioperative management of patients with coronary stents in non-cardiac surgery] |
| Q81624117 | [Preoperative evaluation and perioperative management of patients with increased cardiovascular risk] |